(Q33341214)

English

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase III clinical trial

0 references

author name string

K Fizazi

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

K A Do

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

X Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

L Finn

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C J Logothetis

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R J Amato

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

125-134

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Chemotherapy in adult germ cell tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Continuous infusion chemotherapy: a critical review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF005

21 January 2018

Identifiers

10.1093/ANNONC/MDF005

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33341214&oldid=1536772413"